Clinical trial
A Randomized, Double Blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
NCT01314495 is registered in ClinicalTrials.gov with Julian M. Mackay-Wiggan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double Blind, Placebo Controlled Clinical Trial to Evaluate the Efficacy of Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
- Lead sponsor
- Julian M. Mackay-Wiggan
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- September 30, 2011
- Completion date
- June 30, 2012
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia totalis/universalis